PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada

Go back to PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada
(NASDAQ: PYPD) Delayed: 5.33 -0.06 (1.11%)
Previous Close $5.39    52 Week High
Open $5.39    52 Week Low
Day High $5.57    P/E N/A 
Day Low $5.24    EPS
Volume 87,317